IP Verse

Safe Desmopressin Administration

PatentPatent Analysis

EP2442821

ACERUS PHARMACEUTICALS USA
Application Number
EP10790053A
Filing Date
Jun 15, 2010
Status
Patent Maintained As Amended
Jan 10, 2025
Grant Date
Feb 12, 2025
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2381923B2

Bibliography

The patent EP2442821B2 was granted to Acerus Pharmaceuticals USA on Feb 12, 2025 following the initial filing on Jun 15, 2010 under the application number EP10790053A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

FERRINGMar 12, 2018WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents